Sleep Disturbances and Chronic Widespread Pain

NCT03908905 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2024-02-29

No results posted yet for this study

Summary

Chronic widespread pain (CWP), defined as long-lasting pain in multiple body regions, has a prevalence of 10-14% in Europe and is associated with other physical symptoms such as fatigue and cognitive problems. Individuals with longstanding pain also have a high prevalence of sleep disturbances, and sleep problems can in itself lead to tiredness, lower neurocognitive function and higher pain ratings. However, studies of comorbid sleep problems for individuals with CWP are a lacking, and the primary aim for the present study is to assess the prevalence of sleep disturbances in individuals with CWP, and to see how this covariates with pain, fatigue, activity level, neurocognitive functioning, and biomarkers. As a secondary aim the study will assess a subgroup of the individuals, that has received multimodal pain management treatment, a second time after 6 months to analyze how the prevalence of sleep disturbances and other associated problems covaries over time.

Conditions

  • Chronic Widespread Pain
  • Sleep Disturbance

Interventions

DIAGNOSTIC_TEST

Polysomnography

Sleep screening, neurocognitive assessment, activity monitoring questionnaires, blood sample

Sponsors & Collaborators

  • Uppsala University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2024-12-30
Completion
2025-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03908905 on ClinicalTrials.gov